Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
04/2007
04/03/2007US7198921 Process for producing protein with reduction of acidic sugar chain and glycoprotein produced thereby
04/03/2007US7198915 Preparing modified/artificial polypeptides; mimetics
04/03/2007US7198909 Myeloid precursor cell useful for gene therapy and for modulation of immune responses
04/03/2007US7198905 Method of screening methods prediabetic state and screening reagent
04/03/2007US7198894 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions
04/03/2007US7198892 Hepatitis-C virus type 4, 5 and 6
04/03/2007US7198890 by reacting the biological specimen with cysteine dioxygenase in the absence of a reducing agent, the free cysteine in the specimen is efficiently eliminated at first, and then by reacting it with a reducing agent, cysteines and homocysteines bound to proteins are liberated from the proteins
04/03/2007CA2222141C Alkaline cellulase and method for producing the same
04/03/2007CA2089495C Purified thermostable nucleic acid polymerase enzyme from thermotoga maritima
03/2007
03/30/2007CA2560161A1 Production of recombinant human collagen
03/29/2007WO2007035782A2 Protein kinase c peptide modulators of angiogenesis
03/29/2007WO2007035439A1 Discovery, cloning and purification of thermococcus sp. (strain 9°n-7) dna ligase
03/29/2007WO2007035161A1 New process for converting aromatic halo-substituted dinitriles into halo-substituted cyanocarboxylic acids
03/29/2007WO2007034999A1 Method for production of enzyme
03/29/2007WO2007034782A1 Recombinant vector capable of increasing secretion of koji mold protease
03/29/2007WO2007034693A1 Novel endoribonuclease
03/29/2007WO2007034480A2 Heparanases and splice variants thereof, ponucleotides encoding them and uses thereof
03/29/2007WO2007034262A1 Heterodimeric meganucleases and use thereof
03/29/2007WO2007033928A1 Novel dehydrogenases, the derivatives thereof, and method for the production of optically active alkanols
03/29/2007WO2006130657A3 Stereoselective reduction process for the preparation of pyrrolotriazine compounds
03/29/2007WO2006110508A3 Plants with increased phosphorous uptake
03/29/2007WO2006090810A3 Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
03/29/2007WO2006086454A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
03/29/2007WO2006071603A9 Phosphodiesterase 4d in the ryanodine receptor complex protects against heart failure
03/29/2007WO2006009682A3 Glue compositions for lung volume reduction
03/29/2007WO2006008653A3 Lipolytic enzyme uses thereof in the food industry
03/29/2007WO2006008653A2 Lipolytic enzyme uses thereof in the food industry
03/29/2007US20070074310 Plants synthesizing a modified starch, a process for the generation of the plants, their use, and the modified starch
03/29/2007US20070074309 Polypeptides and expression vectors host cell and transgenic plants with nucleic acid and stress resistance; antifungal agent
03/29/2007US20070074307 Citrus tristeza virus resistance genes and methods of use
03/29/2007US20070072807 Method of screening compounds
03/29/2007US20070072794 Novel genes and proteins encoded thereby
03/29/2007US20070072791 Polypeptides biodrugs with given amino acid sequence which includes phosphorylated serine or threonine; Type II Diabetes and Alzheimer's Disease
03/29/2007US20070072281 Three-dimensional structure of the catalytic domain of protein kinase c theta, methods and uses thereof
03/29/2007US20070072279 Evolved micro-organisms for the production of 1,2-propanediol
03/29/2007US20070072278 Reductase gene and use thereof
03/29/2007US20070072277 Such as monatin by exposing typtophan to enzyme which converts tryptophan to 3-indolepyruvic acid which is exposed to enzyme and oxaloacetic/pyruvic acid to form 4-(indol-3-ylmethyl)-4-hydroxy-2-oxoglutaric acid
03/29/2007US20070072273 use in host cells for biosynthesis of fine chemicals such as lysine; gene stability, gene expression or protein secretion/protein folding (SES proteins)
03/29/2007US20070072270 PS4 variant with a proline substitution, derivable from a parent polypeptide, having non-maltogenic exoamylase activity; higher thermostability compared to the parent polypeptide
03/29/2007US20070072269 Ubiquitin-specific protease occurring in the brain and DNA encoding the same
03/29/2007US20070072268 Sulfotransferase and DNA encoding the enzyme
03/29/2007US20070072266 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof
03/29/2007US20070072265 Expression vector comprising nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) proteins for enhancing production of functional heterologous polypeptides
03/29/2007US20070072262 Deletions inactivate arginine and histidine biosynthetic pathways in methylotrophic yeast (Pichia pastoris); arginiosuccinate synthase (ARG1); amino-acid N-acetyltransferase (ARG2), ornithine carbamoyltransferase (ARG3), ATP phosphoribosyltransferase (HIS1), histidinol-phosphatase (HIS2)
03/29/2007US20070072261 Nucleic acids encoding PAK5 polypeptidesm and methods of use thereof
03/29/2007US20070072231 Tumor suppressor gene
03/29/2007US20070072205 Nanomaterial error correction
03/29/2007US20070072192 Novel polypeptides encoded by essential bacterial genes
03/29/2007US20070072185 Carbohydrate-binding modules of a new family
03/29/2007US20070072183 Topoisomerase hybrids and methods of use
03/29/2007US20070071770 Recombinant MVA virus, and the use thereof
03/29/2007US20070071769 Recombinant MVA virus, and the use thereof
03/29/2007US20070071755 Novel nucleolar GTPases and method for controlling proliferation of cells
03/29/2007US20070071752 Sphingosine kinase enzyme
03/29/2007US20070071751 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
03/29/2007US20070071750 Comprises heavy and light chain; treating envenomation by administering to neutralize in vivo effect
03/29/2007US20070071741 OCL-2A3 compositions and uses thereof
03/29/2007US20070071725 Nitric oxide synthase gene transfer
03/29/2007US20070071724 Methods for increasing learning and memory in amyloid-beta-related neurodegenerative disorders by increasing Uch-L1 activity and methods for identifying enhancers of Uch-L1 activity
03/29/2007DE102005046490A1 New nucleic acid molecule comprising promoter, a transcriptable nucleic acid sequence, a first and second nucleic acid sequence for producing modified RNA with transcriptional stability and translational efficiency
03/29/2007DE102005046348A1 New heat-stable enzyme with 3'-5'-exonuclease activity, useful e.g. for preparing templates for dideoxy sequencing and directed mutagenesis, also new nucleic acid encoding it
03/29/2007DE10106163B4 Verfahren zur Herstellung von Kohlenhydraten A process for producing carbohydrates
03/29/2007CA2644089A1 Protein kinase c peptide modulators of angiogenesis
03/29/2007CA2623266A1 Low acrylamide foods and their production comprising reduction of asparagine levels in plants
03/28/2007EP1767650A1 Method of screening compound directly activating glycogen synthase
03/28/2007EP1767644A1 Microbial strains producing sphingosine
03/28/2007EP1767628A1 Process for producing dipeptides or dipeptide derivatives
03/28/2007EP1767624A1 Improved nitrile hydratase
03/28/2007EP1766601A2 Genetically purified gellan gum
03/28/2007EP1766095A2 Detection of protein translocation by beta-galactosidase reporter fragment complementation
03/28/2007EP1766071A2 Double strand compositions comprising differentially modified strands for use in gene modulation
03/28/2007EP1766065A2 COMPOSITIONS AND METHODS FOR SYNTHESIZING cDNA
03/28/2007EP1766052A1 Chimeric gapped oligomeric compositions
03/28/2007EP1766050A1 Assay system using labeled oligonucleotides
03/28/2007EP1766042A2 Diagnostics and therapeutics for diseases associated with chymase (cma1)
03/28/2007EP1766033A2 Genetically modified non-human mammals and cells
03/28/2007EP1766028A1 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities
03/28/2007EP1766026A1 Glucose isomerase mutants
03/28/2007EP1766025A1 Porcine sulfotransferase 2a1 polynucleotide sequence, protein, and methods of use for same
03/28/2007EP1766024A1 Proteins with attached short peptide of acidic amino acids
03/28/2007EP1766023A2 Metabolically engineered cells for the production of polyunsaturated fatty acids
03/28/2007EP1766022A1 Detecting disease association with aberrant glycogen synthase kinase 3 beta expression
03/28/2007EP1766011A1 Polypeptide ligands containing linkers
03/28/2007EP1766009A2 Treatment of neurodegenerative disease through intracranial delivery of sirna
03/28/2007EP1766003A1 Thrombin compositions
03/28/2007EP1766002A1 Stably maintained multiple copies of at least two orf in the same orientation
03/28/2007EP1766001A2 Nocardiopsis proteases
03/28/2007EP1766000A1 Improved methods of producing heterologous proteases
03/28/2007EP1765999A1 Cellulases from rumen
03/28/2007EP1765998A2 Mutant endoglycoceramidases with enhanced synthetic activity
03/28/2007EP1765997A2 Pharmaceutical composition for modulating the activity of triglyceride hydrolase
03/28/2007EP1765996A2 Mammalian endonucleases and methods of use
03/28/2007EP1765995A2 Thermostable y-family polymerases and chimeras
03/28/2007EP1765994A2 Reconstituted histone methyltransferase complex and methods of identifying modulators thereof
03/28/2007EP1765993A2 Truncated st6galnaci polypeptides and nucleic acids
03/28/2007EP1765992A2 Truncated galnact2 polypeptides and nucleic acids
03/28/2007EP1765991A1 Acetyl coa carboxylase splice variant and uses thereof
03/28/2007EP1765978A2 Methods for production of xylitol in microorganisms
03/28/2007EP1765977A2 Flavonoids
03/28/2007EP1765856A2 Rna-dependent dna polymerase from geobacillus stearothermophilus